Filing Details

Accession Number:
0001104659-22-062697
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-19 07:01:36
Reporting Period:
2022-05-18
Accepted Time:
2022-05-19 07:01:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1175151 Cytosorbents Corp CTSO Surgical & Medical Instruments & Apparatus (3841) 980373793
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1647591 G. Michael Bator C/O Cytosorbents Corp.
7 Deer Park Dr., Suite K
Monmouth Junction NJ 08852
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-18 2,000 $2.18 75,800 No 4 P Direct
Common Stock Acquisiton 2022-05-18 2,000 $2.18 77,800 No 4 P Direct
Common Stock Acquisiton 2022-05-18 2,000 $2.20 79,800 No 4 P Direct
Common Stock Acquisiton 2022-05-18 2,000 $2.20 81,800 No 4 P Direct
Common Stock Acquisiton 2022-05-18 2,000 $2.20 83,800 No 4 P Direct
Common Stock Acquisiton 2022-05-18 1,000 $2.21 84,800 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. Includes (a) the following restricted stock units which will vest upon a "Change of Control" of CytoSorbents Corporation, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan: (i) 3,300 restricted stock units granted on March 15, 2018, (ii) 6,000 restricted stock units granted on February 24, 2017, and (iii) 60,000 restricted stock units granted on June 7, 2017, and (b) 15,500 shares of common stock owned by the reporting person, inclusive of 11,000 total shares of common stock purchased on May 18, 2022 and reported on this Form 4.